FR2769505B1 - Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations - Google Patents

Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations

Info

Publication number
FR2769505B1
FR2769505B1 FR9712687A FR9712687A FR2769505B1 FR 2769505 B1 FR2769505 B1 FR 2769505B1 FR 9712687 A FR9712687 A FR 9712687A FR 9712687 A FR9712687 A FR 9712687A FR 2769505 B1 FR2769505 B1 FR 2769505B1
Authority
FR
France
Prior art keywords
cytokines
administration
compositions
oral mucosa
mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9712687A
Other languages
English (en)
Other versions
FR2769505A1 (fr
Inventor
Michael Gerard Tovey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9712687A priority Critical patent/FR2769505B1/fr
Priority to ZA989206A priority patent/ZA989206B/xx
Priority to ES98947739T priority patent/ES2252859T3/es
Priority to TW087116780A priority patent/TWI233357B/zh
Priority to EP98947739A priority patent/EP1027068B1/fr
Priority to CA002312906A priority patent/CA2312906A1/fr
Priority to AT98947739T priority patent/ATE313331T1/de
Priority to IL13660498A priority patent/IL136604A0/xx
Priority to DE69832902T priority patent/DE69832902T2/de
Priority to AU94556/98A priority patent/AU762360B2/en
Priority to NZ504955A priority patent/NZ504955A/xx
Priority to ARP980105057A priority patent/AR015956A1/es
Priority to CNB988120232A priority patent/CN1259104C/zh
Priority to PCT/IB1998/001720 priority patent/WO1999018992A1/fr
Publication of FR2769505A1 publication Critical patent/FR2769505A1/fr
Application granted granted Critical
Publication of FR2769505B1 publication Critical patent/FR2769505B1/fr
Priority to HK01101085A priority patent/HK1030150A1/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR9712687A 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations Expired - Fee Related FR2769505B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR9712687A FR2769505B1 (fr) 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations
ZA989206A ZA989206B (en) 1997-10-10 1998-10-08 Oromucosal cytokine compositions and uses thereof
ARP980105057A AR015956A1 (es) 1997-10-10 1998-10-09 Composiciones de citoquinas oromucosales y usos de las mismas
EP98947739A EP1027068B1 (fr) 1997-10-10 1998-10-09 Compositions a base de cytokine pour les muqueuses buccales et utilisation de ces compositions
CA002312906A CA2312906A1 (fr) 1997-10-10 1998-10-09 Compositions a base de cytokine pour les muqueuses buccales et utilisation de ces compositions
AT98947739T ATE313331T1 (de) 1997-10-10 1998-10-09 Oromukosal-zytokin-zusammensetzungen und ihre verwendung
IL13660498A IL136604A0 (en) 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof
DE69832902T DE69832902T2 (de) 1997-10-10 1998-10-09 Oromukosal-zytokin-zusammensetzungen und ihre verwendung
ES98947739T ES2252859T3 (es) 1997-10-10 1998-10-09 Composiciones de citoquina oromucosales y utilizacion de las mismas.
NZ504955A NZ504955A (en) 1997-10-10 1998-10-09 The use of TH1 and TH2 cytokines for the preparation of an oromucosal medicament
TW087116780A TWI233357B (en) 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof
CNB988120232A CN1259104C (zh) 1997-10-10 1998-10-09 口粘膜细胞因子组合物及其应用
PCT/IB1998/001720 WO1999018992A1 (fr) 1997-10-10 1998-10-09 Compositions a base de cytokine pour les muqueuses buccales et utilisation de ces compositions
AU94556/98A AU762360B2 (en) 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof
HK01101085A HK1030150A1 (en) 1997-10-10 2001-02-14 Oromucosal cytokine compositions and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712687A FR2769505B1 (fr) 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2769505A1 FR2769505A1 (fr) 1999-04-16
FR2769505B1 true FR2769505B1 (fr) 2000-06-30

Family

ID=9512087

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9712687A Expired - Fee Related FR2769505B1 (fr) 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations

Country Status (15)

Country Link
EP (1) EP1027068B1 (fr)
CN (1) CN1259104C (fr)
AR (1) AR015956A1 (fr)
AT (1) ATE313331T1 (fr)
AU (1) AU762360B2 (fr)
CA (1) CA2312906A1 (fr)
DE (1) DE69832902T2 (fr)
ES (1) ES2252859T3 (fr)
FR (1) FR2769505B1 (fr)
HK (1) HK1030150A1 (fr)
IL (1) IL136604A0 (fr)
NZ (1) NZ504955A (fr)
TW (1) TWI233357B (fr)
WO (1) WO1999018992A1 (fr)
ZA (1) ZA989206B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
GB0001710D0 (en) * 2000-01-25 2000-03-15 Pharma Pacific Pty Ltd Therapeutic treatment
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP1250933A1 (fr) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Vaccins comprenant en tant qu'adjuvant l'IFN type I à dose élevée
EP1631312B1 (fr) 2003-04-23 2008-09-10 Medarex, Inc. Compositions et techniques destinees a la therapie d'une maladie intestinale inflammatoire
DK2662390T3 (da) 2004-06-21 2017-11-06 Squibb & Sons Llc Interferon alpha receptor 1-antistoffer og anvendelse heraf
WO2008109953A1 (fr) * 2007-03-14 2008-09-18 Sai Ying Ko Procédé de traitement du cancer par l'administration mucosale d'interleukine
DE102007014752A1 (de) 2007-03-28 2008-10-02 Dusek, Niels, Dr. Verwendung von humanidentischem oder humanaequivalentem rekombinantem Interleukin-2 (heqlL-2) als Therapeutikum in der Human- und Veterinärmedizin
CN102462837B (zh) * 2010-11-19 2016-08-03 生物林格斯Ip有限公司 抗炎组合物
ES2811624T3 (es) 2011-03-11 2021-03-12 Hopitaux Paris Assist Publique Régimen de dosificación de IL-2 para tratar lupus eritematoso sistémico
EP2683395B1 (fr) 2011-03-11 2018-08-01 Assistance Publique - Hôpitaux de Paris Utilisation d'il-2 à faible dose pour le traitement de troubles du diabète de typ i

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286748A (en) * 1981-01-05 1994-02-15 Eby Iii George A General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
WO1991007186A1 (fr) * 1989-11-21 1991-05-30 The University Of Melbourne Compositions et procedes anti-inflammatoires
US5215741A (en) * 1990-10-30 1993-06-01 Amarillo Cell Culture Company, Incorporated Method for prevention of parasite infections
DK0563254T3 (da) * 1990-12-19 1996-02-12 Schering Corp Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
WO1997025862A1 (fr) * 1996-01-19 1997-07-24 Mcgill University Composition et methode de pretraitement de l'hepatite

Also Published As

Publication number Publication date
FR2769505A1 (fr) 1999-04-16
AR015956A1 (es) 2001-05-30
ZA989206B (en) 1999-04-12
DE69832902T2 (de) 2006-08-10
HK1030150A1 (en) 2001-04-27
AU9455698A (en) 1999-05-03
NZ504955A (en) 2002-11-26
DE69832902D1 (de) 2006-01-26
EP1027068A1 (fr) 2000-08-16
CN1259104C (zh) 2006-06-14
WO1999018992A1 (fr) 1999-04-22
ATE313331T1 (de) 2006-01-15
IL136604A0 (en) 2001-06-14
AU762360B2 (en) 2003-06-26
ES2252859T3 (es) 2006-05-16
CA2312906A1 (fr) 1999-04-22
CN1281368A (zh) 2001-01-24
EP1027068B1 (fr) 2005-12-21
TWI233357B (en) 2005-06-01

Similar Documents

Publication Publication Date Title
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
EE9700192A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
BR9602759A (pt) Composição farmacêutica oral organoleticamente aceitável
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
IL116673A (en) Stable oral pharmaceutical composition containing an acid labile benzimidazole
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
FR2769505B1 (fr) Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations
BR9602758A (pt) Composição farmacêutica oral organoleticamente aceitável
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69828097D1 (de) Mundpflegezusammensetzung
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
BR9606974A (pt) Composições orais
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
IT1283608B1 (it) Composizione farmaceutica per la terapia orale diuretica ed antiipertensiva.
KR970073587A (ko) 오메프라졸 구강점막 부착 정제 조성물
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
SE9402925D0 (sv) Novel oral pharmaceutical composition

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20090630